A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment.

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer ...

NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...

Cancer tumors are surrounded by immune cells, but not all of those cells help the body fight back. Some support anti-cancer ...

Scientists have long observed that although cancer risk rises with age, rates appear to decline somewhat among people over 80 ...

Readouts in rare blood cancers like myelofibrosis, WM and CLL are attracting keen interest at this year’s ASCO conference.

Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, ...